MedPath

Effectiveness of Propolis Mouthwash on Gingivitis

Not Applicable
Completed
Conditions
Gingivitis
Interventions
Registration Number
NCT04032548
Lead Sponsor
Mahsa University
Brief Summary

Mouthrinses have been in used for centuries as breath fresheners, medicaments, and antiseptics. Recently, propolis has caught the eyes of dentists worldwide and researches are being carried out to infuse the usage of propolis in the dental health care treatments. There is belief that propolis may have a role as a tooth decay prophylaxis and help heal oral ulcers. Propolis is used as mouthwash, toothpaste, oral gel, and throat lozenges because of its proclaimed antibacterial and anti-inflammatory properties. Propolis has shown activity against common periodontal microorganisms, such as Candida species and the Streptococci mutans in vitro studies. Till date, no study has evaluated the clinical and microbiological effects of Malaysian Propolis as a mouthwash. Thus, the present study is designed to evaluate the effectiveness of Propolis as a mouthwash in the reduction of Plaque and gingivitis.The aim of the study is to assess and compare the effectiveness of Propolis mouthrinse with Chlorhexidine mouthrinse.

Detailed Description

The Randomized Controlled Clinical study with latin-square cross-over design would be used to assess and compare the effectiveness of Propolis and Chlorhexidine mouthrinse on gingivitis. Subjects with chronic generalized gingivitis with age group of 18-30 years will be selected for the study as the target population. Subjects who meet the inclusion and exclusion criteria will be selected and screened for the plaque and gingival status before including them in the study. They will be randomly divided into three groups.

Group 1: 15 subjects (Placebo mouthwash) Group 2: 15 subjects (Propolis mouthwash) Group 3: 15 subjects (Chlorhexidine mouthwash)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Gingival index >1
  • Periodontal pocket depth ≤ 3 mm
  • Clinical attachment loss "0"
  • Provision of written informed consent
  • Good systemic health.
Exclusion Criteria
  • Severe periodontal disease, as characterized by purulent exudates, generalized mobility, and/or severe recession
  • Any condition that requires antibiotic premedication for the administration of a dental prophylaxis.
  • Self-reported pregnancy, intent to become pregnant during the study, or breast-feeding.
  • Any diseases or condition that could be expected to interfere with the safe completion of the study.
  • History of antibiotic use in the previous 3 months.
  • Individuals with orthodontic appliances or prosthetic appliances that would interfere with evaluation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo mouthwashSubjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.
PropolisPropolis mouthwashSubjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.
ChlorhexidineChlorhexidine mouthwashSubjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.
Primary Outcome Measures
NameTimeMethod
Change in Gingival Index (GI)Difference for the mean gingival score from baseline to 21 days.

The primary outcome variable was the differences for the mean gingival score from baseline to 21 days.

The gingival index ranges from 0-3 which is a continuous scale. '0' indicates normal healthy gingiva without inflammation (better score) ; and score '3' indicates severe gingival inflammation (worst score).

The index teeth of each participant were examined and gingival status is scored. The score for each subject is added and divided by the total number of teeth examined.

The average/mean gingival score obtained from each subject is added for all the subjects and divided by the total number of participants. Higher score indicates worst score.

Change in Plaque Index (PI)Difference in the mean reduction of Plaque score from baseline to 21 days.

The primary outcome variable was the differences for the mean plaque score from baseline to 21 days.

The plaque index ranges from 0-3 which is a continuous scale. '0' indicates no plaque on teeth (better score) ; and score '3' indicates abundance of plaque on the teeth (worst score).

The index teeth of each participant were examined and plaque score is recorded. The score for each subject is added and divided by the total number of teeth examined.

The average/mean plaque score obtained from each subject is added for all the subjects and divided by the total number of participants. Higher score indicates worst score.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shilpa

🇲🇾

Jenjarum, Selangor, Malaysia

© Copyright 2025. All Rights Reserved by MedPath